Viagra With Dapoxetine

Critical Warnings & Restrictions

Basic Viagra With Dapoxetine Information

• INN (International Nonproprietary Name): Sildenafil (a phosphodiesterase type 5 inhibitor) and Dapoxetine (a selective serotonin reuptake inhibitor).
• Brand Names Available In United Kingdom: Common global brand names include Super P‑Force, Sildigra Super Power, Manforce Duralong, Extra Super Tadarise and generic Sildenafil Dapoxetine Tablets.
• ATC Code: The fixed combination does not have a unique WHO ATC code; Sildenafil is G04BE03 and Dapoxetine is listed under N06AB62.
• Forms & Dosages: Oral film‑coated tablets commonly sold as 100 mg Sildenafil + 60 mg Dapoxetine, 50 mg Sildenafil + 30 mg Dapoxetine, or 100 mg Sildenafil + 30 mg Dapoxetine in blister strips of 4 or 10.
• Manufacturers In United Kingdom: Not specified; major manufacturers are Indian firms such as Sunrise Remedies, Fortune Healthcare, Centurion Laboratories and Ajanta Pharma, with products supplied via e‑pharmacies.
• Registration Status In United Kingdom: The fixed combination is not approved by FDA or EMA and has limited formal approval internationally; the fixed product does not have a widely listed UK marketing authorisation and may be supplied as an imported or unlicensed preparation when clinically justified.
• OTC / Rx Classification: Prescription‑only medicine (POM) in regulated markets and not available over‑the‑counter.

High-Risk Groups

Sildenafil plus dapoxetine is prescription‑only and not suitable for everyone.

Absolute contraindications include concurrent nitrate therapy, severe cardiac disease (recent myocardial infarction, stroke or unstable angina), moderate to severe hepatic or renal impairment, known hypersensitivity to sildenafil or dapoxetine, and major psychiatric disorders such as bipolar disorder or major depression where dapoxetine (an SSRI) is inappropriate.

Elderly patients often have increased sensitivity to both drugs and should start at lower doses with monitoring of blood pressure and mood state.

Pregnancy and breastfeeding are not applicable because this product is for adult men only, but partners should avoid exposure to tablet contents and keep medicine away from children.

• Absolute Contraindications: Nitrates, recent MI/stroke, unstable angina, moderate–severe hepatic or renal impairment, hypersensitivity to components, major psychiatric illness.
• Relative Contraindications: Mild hepatic/renal impairment, stable cardiovascular disease (assess risk), use with alpha‑blockers or multiple antihypertensives, recent MAO inhibitor use without 14‑day washout.

• Pre‑prescription Screening Checklist:
• Cardiac history including angina, prior MI or stroke.
• Current medicines (nitrates, antihypertensives, antidepressants, CYP3A4 inhibitors).
• Liver and kidney function status.
• Mood or psychiatric history including suicidal ideation.

Urgent red flags that require immediate A&E assessment include priapism lasting more than four hours, sudden severe hypotension, syncope, and new severe chest pain.

Clinicians in the UK follow MHRA and NHS guidance when assessing suitability, and combined products are often handled as unlicensed “specials” requiring documented clinical justification.

Interaction With Activities

Dizziness, somnolence and orthostatic hypotension are reported and the combination can increase these risks compared with either drug alone.

If you feel lightheaded, faint, drowsy or notice blurred vision after dosing you must not drive, operate heavy machinery or perform safety‑critical work until fully recovered.

• Immediate Actions If Dizzy: Sit or lie down until symptoms resolve and take fluids if tolerated.
• When To Avoid Driving: Do not drive if you experience any dizziness, faintness, visual disturbance or somnolence after taking the tablet.
• Employer Advice: Disclosure to an employer should be limited to what is clinically necessary; occupational fitness advice may be required for safety‑sensitive roles.

Drivers must inform the DVLA if a medical condition or medication affects driving ability and should report adverse events to the MHRA Yellow Card scheme.

Q&A — “Can I Drive After Taking It In The UK?”

Short answer: No, not if you feel unwell.

Only drive if you feel fully alert and have no dizziness, visual disturbance or drowsiness after taking the tablet.

If you experience any of these effects do not drive and seek clinical advice.

Report suspected adverse reactions using the MHRA Yellow Card system.

Usage Basics (INN, Brand Names, UK Availability)

INN, Brand Names Available In The UK

The INNs are Sildenafil and Dapoxetine.

Common international brands for the fixed combination include Super P‑Force, Sildigra Super Power, Manforce Duralong and Extra Super Tadarise, while Priligy is the reference brand for dapoxetine as a single agent.

Packaging is typically film‑coated tablets in blister strips of four or ten with batch and dosing information on the box.

• Forms: Film‑coated oral tablets.
• Typical Strengths: 100 mg Sildenafil + 60 mg Dapoxetine; 50 mg Sildenafil + 30 mg Dapoxetine; 100 mg Sildenafil + 30 mg Dapoxetine.

In the UK the fixed combination generally does not hold an MHRA marketing authorisation and clinicians may prescribe imported or unlicensed preparations where clinically indicated.

Legal Classification

This product is a Prescription‑Only Medicine (POM) in the UK.

It cannot be sold over the counter and requires a valid prescription from a clinician.

High‑street chains and registered online pharmacies only dispense on receipt of a legitimate prescription and after pharmacist counselling.

Dosing Guide (NHS‑Style Regimens & Adjustments)

Standard Regimens (NHS Guidelines)

The usual regimen is on‑demand dosing with one tablet taken 1–3 hours before sexual activity.

Commonly marketed starting doses are Sildenafil 100 mg combined with Dapoxetine 60 mg, with lower combinations (50/30 mg or 100/30 mg) available for dose adjustments.

• Take one tablet 1–3 hours before sex.
• Do not take more than one dose within 24 hours.
• Not intended for daily chronic use.

Monitor efficacy and side effects; if partial response is seen consider a 3–6 month trial with regular review by the prescriber.

Adjustments For Comorbidities

Elderly patients may require lower starting doses and closer monitoring for hypotension and agitation.

Moderate to severe hepatic or renal impairment contraindicates use of the combination.

Concomitant use of potent CYP3A4 inhibitors (for example some azole antifungals or ritonavir) may increase sildenafil levels and require dose review.

• Triggers For Dose Reduction: Advanced age, low body weight, coadministration of CYP3A4 inhibitors, borderline blood pressure.
• Monitoring Parameters: Blood pressure, mood changes, visual symptoms and signs of serotonin syndrome if other serotonergic agents are present.

Q&A — “What If I Miss A Dose?”

Because dosing is on‑demand there is no routine missed‑dose action; if sexual activity is postponed do not repeat the dose within 24 hours.

If you accidentally take more than the recommended dose seek urgent medical attention for priapism, severe hypotension, agitation or features suggesting serotonin syndrome.

Interaction Chart (Foods, Drinks, Medicines)

Food And Drinks

Alcohol increases the risk of dizziness, orthostatic hypotension and impaired sexual performance and may add to dapoxetine‑related sedation and risk of syncope.

Modest caffeine intake is not a prohibitive interaction but may increase anxiety and heart rate in some men.

Grapefruit juice can affect CYP enzymes and caution is advised with high intake around dosing.

Common Drug Conflicts

Major and clinically important interactions include nitrates (absolute contraindication), alpha‑blockers and other antihypertensives (additive hypotension), MAO inhibitors (require 14‑day washout), potent CYP3A4 inhibitors (increase sildenafil exposure) and other serotonergic medicines (risk of serotonin syndrome with dapoxetine).

• Top Interacting Drug Classes: Nitrates, alpha‑blockers, other SSRIs/SNRIs/triptans, MAO inhibitors, potent CYP3A4 inhibitors, antihypertensives, antipsychotics (monitor for QT issues), strong CYP inducers.
• Always check the patient’s full medication list before prescribing.

Clinicians and pharmacists should report suspected adverse drug reactions via the MHRA Yellow Card scheme to monitor evolving safety signals.

User Reports & Trends (NHS Choices, Patient.info, Forums)

Patient reports from UK sources describe improved intercourse duration and better ejaculatory control in many men when the combination is used appropriately.

Common complaints mirror trial data and include nausea, headache, dizziness, transient visual disturbance and sleep disruption related to dapoxetine.

Online forum themes include privacy concerns, variable NHS access and mixed experiences with online pharmacies; convenience is praised but users warn about counterfeit and unregulated suppliers.

• Pros: Improved erection quality, increased intravaginal ejaculatory latency, convenience of a single tablet for coexisting ED and PE.
• Cons: Side effects such as dizziness and nausea, cost, and variable access through NHS pathways.

A simple checklist for readers evaluating reviews: verify MHRA/GPhC registration, check for pharmacist contact details, prefer sources that cite clinical trials or NHS/clinic guidance, and beware anecdotal claims without evidence.

Clinicians should discuss realistic expectations and document baseline symptoms and outcomes during follow‑up.

Access & Purchase Options (High‑Street And Online)

High‑Street Pharmacies & Private Clinics

High‑street chains like Boots, LloydsPharmacy and Superdrug dispense only on a valid prescription and pharmacists will provide counselling at point of supply.

Sexual health clinics and GPs can assess need and issue NHS or private prescriptions depending on clinical appropriateness and local policies.

• Bring a current medicines list, sexual history, and any relevant clinic letters to an appointment.

Online Pharmacies And NHS E‑Prescriptions

Registered UK online pharmacies and e‑clinics offer remote consultations and e‑prescriptions but must be registered with the General Pharmaceutical Council and follow MHRA rules.

Verify provider identity, pharmacist availability, UK contact address and authenticity of the prescription before purchase.

• Safe‑Purchase Checklist: GPhC registration, MHRA compliance, patient information leaflet included, contactable pharmacist, clear returns and delivery policy.

In our online pharmacy, viagra with dapoxetine is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Mechanism & Pharmacology (Simplified + Clinical Terms)

Simplified Explanation

Sildenafil is a phosphodiesterase type‑5 (PDE5) inhibitor that amplifies nitric oxide/cGMP signalling to increase penile blood flow and support erection.

Dapoxetine is a short‑acting selective serotonin reuptake inhibitor that prolongs time to ejaculation by modulating central serotonergic pathways.

• PDE5 Inhibitor: Enhances erection by increasing blood flow to the penis.
• SSRI (Short‑Acting): Extends ejaculatory latency when taken on demand.
• On‑Demand Dosing: Medication is taken shortly before sexual activity rather than daily.

Clinical Terms (Onset, Half‑Life, Metabolism)

Sildenafil generally has an onset of 30–60 minutes and is metabolised mainly by CYP3A4.

Dapoxetine is designed for rapid absorption and a short half‑life to allow on‑demand use and is metabolised via CYP pathways.

Combined use may improve sexual satisfaction but increases the chance of overlapping adverse effects such as dizziness, orthostatic hypotension and somnolence.

Indications & Off‑Label Uses (MHRA & NHS Practice)

MHRA‑Approved Uses (Individual Components)

Sildenafil is licensed for erectile dysfunction and dapoxetine (Priligy) is licensed for premature ejaculation as single agents.

The fixed sildenafil plus dapoxetine combination generally does not have a UK marketing authorisation and may be supplied as an unlicensed product when clinically justified.

• Licensed Indications: Sildenafil for ED; Dapoxetine for PE (as individual products).

Off‑Label Practices In NHS And Private Care

Clinicians sometimes prescribe the combination off‑label or via imported unlicensed supplies for men with coexisting ED and PE who have not responded to monotherapy.

• Obtain informed consent, explain unlicensed status, document clinical rationale and plan regular follow‑up for safety and effectiveness.
• Discuss rare risks including mood changes and possible suicidal ideation linked to SSRIs.

Key Clinical Findings (UK/EU Studies 2022–2025 Summary)

Although no widespread regulatory approval exists for a fixed combination, trials and observational studies to 2025 report improved intercourse success and ejaculatory control when a PDE5 inhibitor is combined with dapoxetine in selected men.

Reported benefits include longer intravaginal ejaculatory latency time (IELT), improved erection quality and higher patient satisfaction scores.

Harms reported more frequently include dizziness, nausea and orthostatic symptoms, with rare psychiatric events potentially attributable to dapoxetine.

Evidence quality varies and some studies are industry‑sponsored or originate from regions where fixed combinations are marketed; clinicians should align interpretation with MHRA and local formulary guidance.

Alternatives Matrix (NHS Alternatives & Pros/Cons)

NHS Prescribing Alternatives

Pros And Cons Checklist

• Assess comorbidities such as cardiac, hepatic and renal disease before choosing therapy.
• Consider interaction with current medications, occupation and driving responsibilities.
• Patient preference for on‑demand versus daily regimens matters for adherence and satisfaction.
• Start with monotherapy or non‑pharmacological options when appropriate and reserve combination therapy for confirmed dual‑diagnosis and after assessment.

Common Questions From UK Consultations

• Can I Get This On The NHS? — Possible if clinically justified, but local formularies vary and many GPs prefer separate licensed drugs or referral to sexual health clinics; England prescription charge normally applies unless exempt.
• Is It Safe With My Antihypertensive? — There is a potential hypotension risk; prescriber must review for alpha‑blocker use and monitor blood pressure.
• What Side Effects Should I Expect? — Headache, flushing and nasal congestion from sildenafil; nausea, insomnia and anxiety from dapoxetine; combined risks include dizziness and orthostatic hypotension.
• Privacy And Online Purchase — Use GPhC and MHRA‑registered services and expect pharmacist counselling and verifiable contact details.

• Top 5 Patient Safety Tips:
• Disclose all medicines and health conditions at consultation.
• Avoid nitrates and be cautious with alcohol.
• Do not drive if unwell after dosing.
• Report adverse events to MHRA Yellow Card.

NHS Cost & Access Comparison

• Check for additional fees such as consultation charges, postage, and handling for imported or unlicensed products.
• Verify pharmacy registration and request a patient information leaflet with every supply.

Registration & Regulation

MHRA Approval Process & Unlicensed Use

The fixed sildenafil+dapoxetine combination has limited formal approval internationally and lacks widespread EMA/FDA licensing.

In the UK prescribers may supply unlicensed “specials” when clinically justified under MHRA rules but must document the rationale and inform the patient about unlicensed status.

• Prescribing Documentation Elements For Unlicensed Medicines:
• Clinical indication and why licensed alternatives are unsuitable.
• Informed consent noting unlicensed status and potential risks.
• Planned monitoring and follow‑up arrangements.

NHS Prescribing Framework

GPs, sexual health clinics and private prescribers follow local formularies and NHS medicines management policies when issuing prescriptions.

Pharmacies must keep dispensing records and supply patient information leaflets and should report suspected adverse reactions to the MHRA Yellow Card scheme.

Storage & Handling (UK Household Guidance)

UK Household Storage

Store tablets at 15–30°C in the original blister packaging to protect from moisture, particularly important in humid bathrooms and kitchens common in UK homes.

Avoid storing medicines in bathrooms or near sinks where steam and dampness can affect stability.

• Ideal storage spots: a cool, dry cupboard outside the kitchen/bathroom, bedside drawer (away from heat sources), or a locked medicines box.
• When travelling carry tablets in original packaging and avoid exposure to prolonged high temperatures.

Guidance From NHS And Pharmacists

Return unused or expired medicines to a pharmacy for safe disposal rather than placing them in household bins or sinks.

Keep the patient information leaflet for batch and expiry details and do not split film‑coated tablets.

Guidelines For Proper Use (Pharmacist Counselling & NHS Safety Advice)

UK Pharmacist Counselling Style

Pharmacists should assess indication, cardiac history, hepatic/renal function, mood and psychiatric history and current medications including nitrates and CYP3A4 modulators.

Provide clear counselling on timing (take 1–3 hours before sexual activity), maximum frequency (once per 24 hours), likely side effects and urgent symptoms that need emergency care.

• Counselling Checklist: indication, full med list, allergies, driving/occupation risks, alcohol use, and counselling on priapism and signs of serotonin syndrome.

NHS Patient Safety Advice

Arrange baseline blood pressure and cardiac assessment where indicated and document consent particularly if the product is unlicensed.

Plan follow‑up to assess efficacy and adverse effects and encourage reporting of adverse events to the MHRA Yellow Card scheme.

Discuss psychological factors and consider referral to sexual health or psychosexual therapy when appropriate.

Delivery Across United Kingdom

Closing Notes And Practical Examples

A 58‑year‑old man with both erectile dysfunction and premature ejaculation who tried sildenafil alone and dapoxetine alone with partial benefit might be considered for combined therapy after cardiac and psychiatric assessment.

Always document the discussion, obtain informed consent if prescribing an unlicensed product and arrange follow‑up to review efficacy and tolerability.

Keep emergency advice clear: if an erection lasts longer than four hours or you develop chest pain, severe fainting or worrying thoughts contact A&E immediately.

For any supply questions choose a GPhC‑registered pharmacy and ask to speak to the pharmacist for personalised counselling.